搜索





搜索





市场行情
/
股票
/
stok
/

Stoke Therapeutics Inc

STOK

添加自选

29.320USD

+0.020+0.07%

收盘 07-27 16:00（美东）报价延迟15分钟

1.73B总市值

亏损市盈率 TTM

Stoke Therapeutics Inc

29.320

+0.020+0.07%

概览

财务

分析

公司

财务摘要利润表资产负债表现金流量表

STOK 利润表

您可以在这里找到Stoke Therapeutics Inc的年度或季度收入报告，以深入了解Stoke Therapeutics Inc的运营、管理效率和表现。

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

营业总收入

-96.07%6.23M

-93.80%1.40M

117.25%10.63M

186.01%13.82M

3661.12%158.57M

707.07%22.61M

47.94%4.89M

294.72%4.83M

-18.17%4.22M

-14.26%2.80M

13.87%3.31M

-176.79%-2.48M

71.73%5.15M

--3.27M

--2.91M

--3.23M

--3.00M

--0.00

----

--0.00

营业收入

-96.07%6.23M

-93.80%1.40M

117.25%10.63M

186.01%13.82M

3661.12%158.57M

707.07%22.61M

47.94%4.89M

294.72%4.83M

-18.17%4.22M

-14.26%2.80M

13.87%3.31M

-176.79%-2.48M

71.73%5.15M

--3.27M

--2.91M

--3.23M

--3.00M

--0.00

----

--0.00

营业费用

26.03%59.65M

73.27%62.84M

53.95%53.72M

20.32%41.12M

45.23%47.33M

11.98%36.27M

14.26%34.90M

11.02%34.17M

9.20%32.59M

6.39%32.39M

1.63%30.54M

8.12%30.78M

7.36%29.84M

24.13%30.44M

32.49%30.05M

29.23%28.47M

65.18%27.80M

68.15%24.53M

65.44%22.68M

69.30%22.03M

43.39%16.83M

31.79%14.59M

39.31%13.71M

54.08%13.01M

85.62%11.73M

143.68%11.07M

196.71%9.84M

180.56%8.45M

230.65%6.32M

--4.54M

--3.32M

--3.01M

--1.91M

研发费用

21.41%39.67M

78.01%41.70M

69.76%37.70M

22.33%25.86M

46.08%32.68M

7.55%23.42M

9.54%22.20M

2.85%21.14M

13.94%22.37M

3.41%21.78M

0.81%20.27M

11.95%20.55M

7.22%19.63M

33.27%21.06M

40.05%20.11M

30.24%18.36M

84.70%18.31M

77.47%15.80M

77.06%14.36M

76.90%14.10M

37.39%9.91M

25.60%8.90M

24.41%8.11M

32.29%7.97M

74.57%7.21M

135.99%7.09M

192.68%6.52M

219.01%6.02M

230.11%4.13M

--3.00M

--2.23M

--1.89M

--1.25M

折旧摊销及损耗

-7.97%439.00K

-23.00%405.00K

-18.15%442.00K

-18.61%446.00K

-15.28%477.00K

-15.71%526.00K

-15.23%540.00K

-10.31%548.00K

-5.70%563.00K

2.46%624.00K

64.18%637.00K

102.32%611.00K

141.70%597.00K

159.15%609.00K

52.76%388.00K

21.29%302.00K

4.66%247.00K

-5.62%235.00K

8.55%254.00K

11.16%249.00K

22.28%236.00K

79.14%249.00K

85.71%234.00K

113.33%224.00K

141.25%193.00K

85.33%139.00K

96.88%126.00K

144.19%105.00K

150.00%80.00K

--75.00K

--64.00K

--43.00K

--32.00K

营业利润

-148.02%-53.42M

-350.00%-61.44M

-43.62%-43.09M

6.96%-27.30M

492.08%111.24M

53.85%-13.65M

-10.17%-30.00M

11.79%-29.34M

-14.91%-28.37M

-8.87%-29.59M

-0.32%-27.23M

-31.79%-33.26M

0.42%-24.69M

-10.80%-27.18M

-19.68%-27.15M

-14.57%-25.24M

-47.35%-24.80M

-68.15%-24.53M

-65.44%-22.68M

-69.30%-22.03M

-43.39%-16.83M

-31.79%-14.59M

-39.31%-13.71M

-54.08%-13.01M

-85.62%-11.73M

-143.68%-11.07M

-196.71%-9.84M

-180.56%-8.45M

-230.65%-6.32M

---4.54M

---3.32M

---3.01M

---1.91M

净非营业利息收入（费用）

利息收入

17.58%3.40M

21.72%3.62M

-2.31%3.46M

2.54%3.79M

19.08%2.89M

14.80%2.97M

33.72%3.54M

43.94%3.69M

15.36%2.43M

74.92%2.59M

166.43%2.65M

371.88%2.57M

1922.12%2.10M

4008.33%1.48M

2161.36%995.00K

1500.00%544.00K

477.78%104.00K

260.00%36.00K

300.00%44.00K

-32.00%34.00K

-97.33%18.00K

-98.89%10.00K

-99.11%11.00K

-92.05%50.00K

16.21%674.00K

234.81%904.00K

--1.24M

--629.00K

--580.00K

--270.00K

--0.00

其他非经营性收入（费用）

-35.71%18.00K

-154.73%-110.00K

-89.29%3.00K

158.33%28.00K

106.54%28.00K

390.24%201.00K

-31.71%28.00K

-217.07%-48.00K

-1119.05%-428.00K

-2.38%41.00K

0.00%42.00K

50.00%42.00K

162.50%42.00K

180.00%42.00K

162.50%42.00K

833.33%28.00K

-27.27%16.00K

275.00%15.00K

700.00%16.00K

200.00%3.00K

--22.00K

140.00%4.00K

--2.00K

---3.00K

--0.00

---10.00K

--0.00

税前利润

-143.80%-50.00M

-452.70%-57.93M

-49.92%-39.63M

8.61%-23.48M

532.84%114.16M

61.12%-10.48M

-7.69%-26.43M

16.18%-25.70M

-16.98%-26.37M

-5.08%-26.96M

6.01%-24.54M

-24.35%-30.65M

8.54%-22.55M

-4.94%-25.66M

-15.55%-26.11M

-12.22%-24.65M

-46.78%-24.65M

-67.90%-24.45M

-65.13%-22.60M

-69.51%-21.97M

-52.12%-16.79M

-43.32%-14.56M

-59.04%-13.68M

-65.74%-12.96M

-92.25%-11.04M

-137.27%-10.16M

-159.39%-8.60M

-159.77%-7.82M

-200.31%-5.74M

---4.28M

---3.32M

---3.01M

---1.91M

所得税

-100.00%0.00

--0.00

---1.28M

--0.00

--1.28M

----

除税后利润

-144.30%-50.00M

-452.70%-57.93M

-45.09%-38.35M

8.61%-23.48M

527.99%112.88M

61.12%-10.48M

-7.69%-26.43M

16.18%-25.70M

-16.98%-26.37M

-5.08%-26.96M

6.01%-24.54M

-24.35%-30.65M

8.54%-22.55M

-4.94%-25.66M

-15.55%-26.11M

-12.22%-24.65M

-46.78%-24.65M

-67.90%-24.45M

-65.13%-22.60M

-69.51%-21.97M

-52.12%-16.79M

-43.32%-14.56M

-59.04%-13.68M

-65.74%-12.96M

-92.25%-11.04M

-137.27%-10.16M

-159.39%-8.60M

-159.77%-7.82M

-200.31%-5.74M

---4.28M

---3.32M

---3.01M

---1.91M

持续经营利润

-144.30%-50.00M

-452.70%-57.93M

-45.09%-38.35M

8.61%-23.48M

527.99%112.88M

61.12%-10.48M

-7.69%-26.43M

16.18%-25.70M

-16.98%-26.37M

-5.08%-26.96M

6.01%-24.54M

-24.35%-30.65M

8.54%-22.55M

-4.94%-25.66M

-15.55%-26.11M

-12.22%-24.65M

-46.78%-24.65M

-67.90%-24.45M

-65.13%-22.60M

-69.51%-21.97M

-52.12%-16.79M

-43.32%-14.56M

-59.04%-13.68M

-65.74%-12.96M

-92.25%-11.04M

-137.27%-10.16M

-159.39%-8.60M

-159.77%-7.82M

-200.31%-5.74M

---4.28M

---3.32M

---3.01M

---1.91M

归属于母公司的净利润

-144.30%-50.00M

-452.70%-57.93M

-45.09%-38.35M

8.61%-23.48M

527.99%112.88M

61.12%-10.48M

-7.69%-26.43M

16.18%-25.70M

-16.98%-26.37M

-5.08%-26.96M

6.01%-24.54M

-24.35%-30.65M

8.54%-22.55M

-4.94%-25.66M

-15.55%-26.11M

-12.22%-24.65M

-46.78%-24.65M

-67.90%-24.45M

-65.13%-22.60M

-69.51%-21.97M

-52.12%-16.79M

-43.32%-14.56M

-59.04%-13.68M

-65.74%-12.96M

-92.25%-11.04M

-137.27%-10.16M

-159.39%-8.60M

-159.77%-7.82M

-200.31%-5.74M

---4.28M

---3.32M

---3.01M

---1.91M

归属于普通股东的净利润

-144.30%-50.00M

-452.70%-57.93M

-45.09%-38.35M

8.61%-23.48M

527.99%112.88M

61.12%-10.48M

-7.69%-26.43M

16.18%-25.70M

-16.98%-26.37M

-5.08%-26.96M

6.01%-24.54M

-24.35%-30.65M

8.54%-22.55M

-4.94%-25.66M

-15.55%-26.11M

-12.22%-24.65M

-46.78%-24.65M

-67.90%-24.45M

-65.13%-22.60M

-69.51%-21.97M

-52.12%-16.79M

-43.32%-14.56M

-59.04%-13.68M

-65.74%-12.96M

-92.25%-11.04M

-137.27%-10.16M

-159.39%-8.60M

-159.77%-7.82M

-200.31%-5.74M

---4.28M

---3.32M

---3.01M

---1.91M

基本每股收益

-140.64%-0.79

-432.58%-0.98

-39.47%-0.65

12.66%-0.40

442.07%1.95

69.36%-0.18

15.39%-0.47

33.58%-0.46

-7.60%-0.57

7.84%-0.60

16.30%-0.55

-10.47%-0.69

19.48%-0.53

1.99%-0.65

-7.75%-0.66

-4.93%-0.63

-43.63%-0.66

-59.93%-0.66

-49.47%-0.61

-52.64%-0.60

-36.57%-0.46

-23.63%-0.41

-56.34%-0.41

-51.77%-0.39

-76.90%-0.34

-137.28%-0.34

-140.06%-0.26

-159.76%-0.26

-200.28%-0.19

---0.14

---0.11

---0.10

---0.06

稀释每股收益

-141.72%-0.79

-432.58%-0.98

-39.47%-0.65

12.66%-0.40

433.23%1.90

69.36%-0.18

15.39%-0.47

33.58%-0.46

-7.60%-0.57

7.84%-0.60

16.30%-0.55

-10.47%-0.69

19.48%-0.53

1.99%-0.65

-7.75%-0.66

-4.93%-0.63

-43.63%-0.66

-59.93%-0.66

-49.47%-0.61

-52.64%-0.60

-36.57%-0.46

-23.63%-0.41

-56.34%-0.41

-51.77%-0.39

-76.90%-0.34

-137.28%-0.34

-140.06%-0.26

-159.76%-0.26

-200.28%-0.19

---0.14

---0.11

---0.10

---0.06

每股派息

--0.00

货币单位

--USD

审计意见

----

常见问题

如何在 TradingKey 上查看 Stoke Therapeutics Inc 的利润表？



先看总营收，再依次查看营收成本、毛利润、营业费用、营业利润、税前利润、净利润和每股收益（EPS）。营收反映公司的业务规模，而各项利润和利润率则体现公司能否有效地将营收转化为盈利。

季度利润表和年度利润表有什么区别？



季度利润表反映公司在一个为期三个月的财务季度内的经营表现，年度利润表则汇总整个财年的业绩。季度数据适合用于观察近期发展势头和季节性变化，年度数据则更适合评估长期增长、盈利能力和业务周期。

利润表页面中的同比是什么意思？



同比是指将某项财务指标与上年同期进行比较，例如将本季度营收与去年同一季度的营收进行对比。同比数据有助于投资者观察增长趋势，同时减少正常季节性变化对分析的影响。

分析 STOK 股票时，哪些利润表指标最重要？



重要的指标包括营收增长、毛利润、毛利率、营业利润、营业利润率、净利润、每股收益、研发费用、销售及管理费用以及所得税费用。投资者通常会综合分析这些指标，以判断公司是否正在增长、有效控制成本并提升盈利能力。

Stoke Therapeutics Inc 财年末的营收是多少？



Stoke Therapeutics Inc 2025 财年营收为 184.42M，高于上一财年的36.55M。

Stoke Therapeutics Inc 最近一个季度的营收是多少？



Stoke Therapeutics Inc 最近一个季度的营收为 6.23M，同比增长 -96.07%。

Stoke Therapeutics Inc 全年的净利润是多少？



Stoke Therapeutics Inc 2025 财年净利润为 -6.88M。

Stoke Therapeutics Inc 上一季度的净利润是多少？



Stoke Therapeutics Inc 最近一个季度的净利润为 -50.00M。

Stoke Therapeutics Inc 年度营业利润是多少？



Stoke Therapeutics Inc 2025 财年的营业利润为 -20.59M。

每股收益与利润表有什么关系？



每股收益（EPS）通常以净利润除以流通在外的股份数量计算，用于衡量公司平均每股创造的利润。分析 EPS 时，还应结合股本变化、利润率、现金流和估值指标进行综合判断。